September 01, 2012
1 min read
Save

PRECOMBAT-2

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study aimed to evaluate the safety and efficacy of second-generation drug-eluting stents in patients with unprotected left main coronary artery stenosis.

PRECOMBAT-2